Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Jack Stone*,
- Josephine G Walker1,
- Sandra Bivegete1,
- Adam Trickey1,
- Charles Chasela2,
- Nadiya Semchuk3,
- Yana Sazonova3,
- Olga Varetska3,
- Tetiana Saliuk3,
- Frederick L Altice4,
- Zhanna Tsenilova3,
- Zahedul Islam3,
- Dina Marunko3,
- Bangyuan Wang5,
- Ancella Voets5,
- Revati Chawla5 and
- Peter Vickerman1
- 1Population Health Sciences, University of Bristol, Bristol, UK
- 2Right to Care/EQUIP Health, South Africa
- 3Alliance for Public Health, Kiev, Ukraine
- 4Yale University, Schools of Medicine and Public Health, New Haven, Connecticut, USA
- 5Frontline AIDS, United Kingdom
- ↵*Corresponding author:
Jack Stone, jack.stone{at}bristol.ac.uk, +44 (0) 117 3310002, Address: Office OF17, Oakfield House, Oakfield Grove, Bristol, UK, BS8 2BN
Author contributions PV, JS and JGW developed the initial model aims and analysis plan with BW and ZI. JS performed the model analyses. PV supported the modelling. SB and JGW gathered and analysed the cost data. FLA, CC, ZI, ZT, NS, TS, YS, and OV provided data. JS wrote the first draft of the manuscript. All authors contributed to interpretation of model analyses, writing the manuscript, and have approved the final version.
Posted December 14, 2021.
Evaluating the impact and cost-effectiveness of scaling-up HCV treatment among people who inject drugs in Ukraine
